| Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective … S Denzinger, M Burger, B Walter, R Knuechel, W Roessler, WF Wieland, ... Urology 69 (4), 675-679, 2007 | 324 | 2007 |
| Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort HM Fritsche, M Burger, RS Svatek, C Jeldres, PI Karakiewicz, G Novara, ... European urology 57 (2), 300-309, 2010 | 256 | 2010 |
| Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach? S Denzinger, HM Fritsche, W Otto, A Blana, WF Wieland, M Burger European urology 53 (1), 146-152, 2008 | 249 | 2008 |
| Prediction of progression of non–muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study M Burger, MNM van der Aa, JMM van Oers, A Brinkmann, ... European urology 54 (4), 835-844, 2008 | 219 | 2008 |
| Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort A Aziz, M May, M Burger, RJ Palisaar, QD Trinh, HM Fritsche, M Rink, ... European urology 66 (1), 156-163, 2014 | 212 | 2014 |
| Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma E Dahl, F Wiesmann, M Woenckhaus, R Stoehr, PJ Wild, J Veeck, ... Oncogene 26 (38), 5680-5691, 2007 | 158 | 2007 |
| Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer S Bertz, W Otto, S Denzinger, WF Wieland, M Burger, R Stöhr, S Link, ... European urology 65 (1), 218-226, 2014 | 134 | 2014 |
| Topographical anatomy of periprostatic and capsular nerves: quantification and computerised planimetry R Ganzer, A Blana, A Gaumann, JU Stolzenburg, R Rabenalt, T Bach, ... European urology 54 (2), 353-361, 2008 | 134 | 2008 |
| Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis M Burger, D Zaak, CG Stief, T Filbeck, WF Wieland, W Roessler, ... European urology 52 (1), 142-147, 2007 | 130 | 2007 |
| Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder JMM van Oers, C Adam, S Denzinger, R Stoehr, S Bertz, D Zaak, C Stief, ... International journal of cancer 119 (5), 1212-1215, 2006 | 116 | 2006 |
| Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the … R Mayr, M May, T Martini, M Lodde, E Comploj, A Pycha, J Strobel, ... European urology 62 (4), 662-670, 2012 | 114 | 2012 |
| The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer W Otto, S Denzinger, HM Fritsche, M Burger, WF Wieland, F Hofstädter, ... BJU international 107 (3), 404-408, 2011 | 113 | 2011 |
| Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder R Mayr, M May, T Martini, M Lodde, A Pycha, E Comploj, WF Wieland, ... BJU international 110 (6b), E222-E227, 2012 | 101 | 2012 |
| FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours JMM van Oers, PJ Wild, M Burger, S Denzinger, R Stoehr, E Rosskopf, ... European urology 52 (3), 760-768, 2007 | 100 | 2007 |
| Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases HM Fritsche, M Burger, S Denzinger, W Legal, PJ Goebell, A Hartmann The Journal of urology 180 (5), 1923-1927, 2008 | 99 | 2008 |
| Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 … W Otto, M May, HM Fritsche, D Dragun, A Aziz, M Gierth, L Trojan, ... Gender medicine 9 (6), 481-489, 2012 | 98 | 2012 |
| Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade M Burger, S Denzinger, A Hartmann, WF Wieland, R Stoehr, ... British journal of cancer 96 (11), 1711-1715, 2007 | 97 | 2007 |
| Water-jet–aided transurethral dissection of urothelial carcinoma: A prospective clinical study HM Fritsche, W Otto, F Eder, F Hofstädter, S Denzinger, CG Chaussy, ... Journal of endourology 25 (10), 1599-1603, 2011 | 88 | 2011 |
| Predicting individual outcomes after radical cystectomy: an external validation of current nomograms D Zaak, M Burger, W Otto, PJ Bastian, S Denzinger, CG Stief, H Buchner, ... BJU international 106 (3), 342-348, 2010 | 84 | 2010 |
| Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer R Stoehr, S Zietz, M Burger, T Filbeck, S Denzinger, EC Obermann, ... European urology 47 (1), 58-63, 2005 | 82 | 2005 |
